Download Files:
Brentuximab vedotin
661 CAD – 3,136 CADPrice range: 661 CAD through 3,136 CAD
Products Details
Product Description
– Brentuximab vedotin (SGN-35) is a CD30-targeting antibody-active molecule conjugate (ADC) that combines a CD30 monoclonal antibody with the microtubule disrupting agent monomethylauristatin E for the study of lymphoma.
Web ID
– T76707
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Shea L, et al. Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma. Curr Hematol Malig Rep. 2020 Feb;15(1):9-19.
CAS Number
– 914088-09-8
Molecular Weight
Compound Purity
– 97.73% (SEC-HPLC)
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock